EPOETIN BETA IS EFFECTIVE FOR 'EVER ANAEMIC' PATIENTS WITH MALIGNANCY RECEIVING CHEMOTHERAPY

被引：0
|
作者：
Podolak-Dawidziak, M. [1 ]
Garbaczonek, M. G. [2 ]
机构：
[1] Wroclaw Med Univ, Wroclaw, Poland
[2] Roche Polska, Warsaw, Poland
来源：
HAEMATOLOGICA-THE HEMATOLOGY JOURNAL | 2008年 / 93卷
关键词：
D O I：
暂无
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
1247
引用
收藏
页码：483 / 483
页数：1
相关论文
共 50 条
  • [1] Epoetin beta once-weekly (QW) treatment in anaemic patients with solid tumour receiving chemotherapy
    Spaeth, D.
    Quoix, E.
    Moullet, I.
    Ghomari, K.
    Hacini, M.
    Bergougnoux, L.
    Bleuzen, R.
    Jenabian, A.
    Oudard, S.
    EJC SUPPLEMENTS, 2007, 5 (04): : 150 - 150
  • [2] Economic evaluation in Sweden of epoetin beta with intravenous iron supplementation in anaemic patients with lymphoproliferative malignancies not receiving chemotherapy
    Hedenus, M.
    Nasman, P.
    Liwing, J.
    JOURNAL OF CLINICAL PHARMACY AND THERAPEUTICS, 2008, 33 (04) : 365 - 374
  • [3] IMPACT OF EPOETIN BETA ON EXECUTIVE FUNCTIONS IN ANAEMIC PATIENTS WITH BREAST CANCER RECEIVING CHEMOTHERAPY: RESULTS OF A PROSPECTIVE COHORT STUDY
    Pivot, X.
    Hugonot-Diener, L.
    Coscas, Y.
    Auquier, P.
    Castrec, E.
    Vlamynck, G.
    Bleuzen, P.
    Namer, M.
    Gligorov, J.
    ANNALS OF ONCOLOGY, 2010, 21 : 396 - 396
  • [4] Once-weekly epoetin beta is highly effective in treating anaemic patients with lymphoproliferative malignancy and defective endogenous erythropoietin production
    Cazzola, M
    BRITISH JOURNAL OF HAEMATOLOGY, 2004, 125 (01) : 99 - 100
  • [5] Once-weekly epoetin beta is highly effective in treating anaemic patients with lymphoproliferative malignancy and defective endogenous erythropoietin production
    Cazzola, M
    Beguin, Y
    Kloczko, J
    Spicka, I
    Coiffier, B
    BRITISH JOURNAL OF HAEMATOLOGY, 2003, 122 (03) : 386 - 393
  • [6] Epoetin beta therapy in anaemic breast cancer patients receiving chemotherapy: results of a subgroup from a large prospective cohort study
    Tourani, J.
    Ray-Coquard, I.
    Facon, T.
    Haioun, C.
    Mathoulin-Pelissier, S.
    Ollivier, C.
    Rouanet, S.
    Fellous, M.
    Malek, K.
    Audhuy, B.
    EJC SUPPLEMENTS, 2009, 7 (02): : 278 - 278
  • [7] A phase IV study of Epoetin alfa examining clinical outcomes in anaemic cancer patients receiving chemotherapy
    Glaspy, J
    Bukowski, R
    Steinberg, D
    Taylor, CW
    VadhanRaj, S
    Danna, RP
    Sarokhan, B
    Lonczak, L
    McNeill, M
    EUROPEAN JOURNAL OF CANCER, 1995, 31A : 233 - 233
  • [8] Efficacy of epoetin beta 30,000 IU once weekly in anaemic patients with solid and non-myeloid haematological malignancies receiving chemotherapy
    Spaeth, D
    Mennecier, B
    Hammerer, V
    Barlési, F
    Fiorentini, P
    Bergougnoux, L
    LUNG CANCER, 2005, 49 : S396 - S396
  • [9] Clinical efficacy and optimal use of epoetin beta therapy in anaemic cancer patients
    Ehmer, B
    Roshan, Y
    BRITISH JOURNAL OF HAEMATOLOGY, 1996, 93 : 1024 - 1024
  • [10] Is once-weekly epoetin beta 'highly effective' in treating anaemia in patients with lymphoproliferative malignancy?
    Bokemeyer, C
    Littlewood, T
    Aapro, M
    BRITISH JOURNAL OF HAEMATOLOGY, 2004, 125 (01) : 98 - 99
12345